Toggle navigation
Share
About Us
Vision & Values
Leadership
History
Collaborations
In the Community
Careers
Media Gallery
Contact CTI
Products
PIXUVRI
®
Development
Pipeline
Pacritinib
Pixantrone
Tosedostat
Paclitaxel Poliglumex
Publications
Clinical Trials
Clinical Trial Overview
Physician Resources
Patient Resources
Investors
Overview
News
Stock
Stock Chart
Historical Price Lookup
Investment Calculator
Transfer Agent
SEC Filings
Analyst Coverage
Events & Webcasts
Annual Report
Shareholder Meeting
Financial Details
Trading Statistics
Balance Sheet
Income Statement
Cash Flow
Ratios
Corporate Governance
Committee Composition
Leadership Bios
Board of Directors
Governance Documents
Whistleblower Hotline
Investor FAQ
Information Request
Email Alerts
Investors
Overview
News
Stock
Stock Chart
Historical Price Lookup
Investment Calculator
Transfer Agent
SEC Filings
Analyst Coverage
Events & Webcasts
Annual Report
Shareholders Meeting
Financial Details
Trading Statistics
Balance Sheet
Income Statement
Cash Flow
Ratios
Corporate Governance
Leadership Bios
Board of Directors
Whistleblower Hotline
Investor FAQ
Information Request
Email Alerts
Info Tools
Print Page
Email Page
RSS Feed
Email Alerts
IR Contacts
Tear Sheet
Most Viewed Links
Events & Webcasts
SEC Filings
CTI BioPharma Reports First Quarter 2018 Financial Results
Stock Quote
Annual Report
Historical Price Lookup
Symbol
CTIC (Nasdaq)
CTIC (MTA)
Lookup Date
January
February
March
April
May
June
July
August
September
October
November
December
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
Results
Date Requested
10/15/18
Closing Price
$
1.95
Volume
112,913
Split Adjustment Factor
1:1
Open
$
1.93
Day's High
$
2.11
Day's Low
$
1.92
Data provided by Nasdaq. Minimum 15 minutes delayed.
